uPAR enhances malignant potential of triple-negative breast cancer by directly interacting with uPA and IGF1R

BACKGROUND: Due to lack of a targeted therapy for the triple-negative breast cancer (TNBC) patients, it is important to explore this aggressive breast cancer type in more detail and to establish novel therapeutic approaches. TNBC is defined negative for the protein expression of oestrogen receptor (...

詳細記述

保存先:
書誌詳細
出版年:BMC Cancer
主要な著者: Huber, Michaela C., Mall, Rebecca, Braselmann, Herbert, Feuchtinger, Annette, Molatore, Sara, Lindner, Katrin, Walch, Axel, Gross, Eva, Schmitt, Manfred, Falkenberg, Natalie, Aubele, Michaela
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2016
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4977758/
https://ncbi.nlm.nih.gov/pubmed/27502396
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2663-9
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料